0001493152-26-007468
SEC filingMangoceuticals, Inc. filed an 8-K on February 19, 2026, referencing Item 7.01 with an attached Exhibit 99.1 Press Release that is not deemed 'filed' under Section 18 of the Securities Exchange Act. Item 9.01 discloses the financial statements and exhibits including the press release and cover page interactive data.